[EN] SULFONAMIDES FOR THE MODULATION OF PKM2<br/>[FR] SULFONAMIDES POUR LA MODULATION DE PKM2
申请人:DYNAMIX PHARMACEUTICALS LTD
公开号:WO2012056319A1
公开(公告)日:2012-05-03
The invention relates to sulfonamide compounds and methods for activating PKM2. The compounds and methods are useful in treating or preventing a disease or disorder selected from cancer, cell proliferative disorder, inflammatory disorder, metabolic disorder, and immune system disorder.
Sulfonamides for the Modulation of PKM2
申请人:Becker Oren M.
公开号:US20120108631A1
公开(公告)日:2012-05-03
The invention relates to sulfonamide compounds and methods for activating PKM2. The compounds and methods are useful in treating or preventing a disease or disorder selected from cancer, cell proliferative disorder, inflammatory disorder, metabolic disorder, and immune system disorder.